Discover how CatapultRx helps medicines-manufacturing SMEs access expertise, infrastructure and funding to grow.
- kelseygarbutt
- 5 minutes ago
- 1 min read
The CatapultRx programme is a targeted initiative designed to accelerate the growth of high-potential SMEs in the Medicines Manufacturing sector.
The programme, managed by CPI aims to support the development, delivery or manufacture of medicines, including but not limited to small molecules, biopharmaceuticals, cell and gene therapies and biologics.
